• 39406 Citations
  • 97 Scopus h-Index
1980 …2019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1986 2019

Filter
Article
Article
97 Citations (Scopus)

Losses of chromosomal arms 1p and 19q in the diagnosis of oligodendroglioma. A study of paraffin-embedded sections

Burger, P. C., Minn, A. Y., Smith, J. S., Borell, T. J., Jedlicka, A. E., Huntley, B. K., Goldthwaite, P. T., Jenkins, R. B. & Feuerstein, B. G., 2001, In : Modern Pathology. 14, 9, p. 842-853 12 p.

Research output: Contribution to journalArticle

Oligodendroglioma
Paraffin
Comparative Genomic Hybridization
Astrocytoma
Fluorescence In Situ Hybridization
51 Citations (Scopus)

Loss of expression of the DRR I gene at chromosomal segment 3p21.1 in Renal cell carcinoma

Wang, L., Darling, J., Zhang, J. S., Liu, W., Qian, J., Bostwick, D., Hartmann, L., Jenkins, R. B., Bardenhauer, W., Schutte, J., Opalka, B. & Smith, D. I., Jan 2000, In : Genes Chromosomes and Cancer. 27, 1, p. 1-10 10 p.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Cell Line
Genes
Tumor Suppressor Genes
Yeast Artificial Chromosomes
7 Citations (Scopus)

Loss of markers linked to BRCA1 precedes loss at important cell cycle regulatory genes in epithelial ovarian cancer

Villeneuve, J. B., Silverman, M. B., Alderete, B., Cliby, W. A., Li, H., Croghan, G. A., Podratz, K. C. & Jenkins, R. B., May 1999, In : Genes Chromosomes and Cancer. 25, 1, p. 65-69 5 p.

Research output: Contribution to journalArticle

cdc Genes
Regulator Genes
Allelic Imbalance
Tumor Suppressor Genes
Neoplasms
76 Citations (Scopus)

Loss of p53 and c-myc overrepresentation in stage T2-3 N1-3M0 prostate cancer are potential markers for cancer progression

Qian, J., Hirasawa, K., Bostwick, D. G., Bergstralh, E. J., Slezak, J. M., Anderl, K. L., Borell, T. J., Lieber, M. M. & Jenkins, R. B., 2002, In : Modern Pathology. 15, 1, p. 35-44 10 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Lymph Nodes
Neoplasm Metastasis
Neoplasms
Control Groups
34 Citations (Scopus)

Mapping and gene expression profile of the minimally overrepresented 8q24 region in prostate cancer

Tsuchiya, N., Kondo, Y., Takahashi, A., Pawar, H., Qian, J., Sato, K., Lieber, M. M. & Jenkins, R. B., 2002, In : American Journal of Pathology. 160, 5, p. 1799-1806 8 p.

Research output: Contribution to journalArticle

Transcriptome
Prostatic Neoplasms
Expressed Sequence Tags
Prokaryotic Initiation Factor-3
Eukaryotic Initiation Factor-3
78 Citations (Scopus)

Mapping of the chromosome 19 q-arm glioma tumor suppressor gene using fluorescence in situ hybridization and novel microsatellite markers

Smith, J. S., Tachibana, I., Lee, H. K., Qian, J., Pohl, U., Mohrenweiser, H. W., Borell, T. J., Hosek, S. M., Soderberg, C. L., Von Deimling, A., Perry, A., Scheithauer, B. W., Louis, D. N. & Jenkins, R. B., Sep 2000, In : Genes Chromosomes and Cancer. 29, 1, p. 16-25 10 p.

Research output: Contribution to journalArticle

Chromosomes, Human, Pair 19
Tumor Suppressor Genes
Fluorescence In Situ Hybridization
Glioma
Microsatellite Repeats
6 Citations (Scopus)

Mate pair sequencing improves detection of genomic abnormalities in acute myeloid leukemia

Aypar, U., Smoley, S. A., Pitel, B. A., Pearce, K. E., Zenka, R. M., Vasmatzis, G., Johnson, S. H., Smadbeck, J., Peterson, J. F., Geiersbach, K. B., Van Dyke, D. L., Thorland, E. C., Jenkins, R. B., Ketterling, R. P., Greipp, P. T., Kearney, H. M., Hoppman, N. L. & Baughn, L., Jan 1 2019, In : European Journal of Haematology. 102, 1, p. 87-96 10 p.

Research output: Contribution to journalArticle

Acute Myeloid Leukemia
Cytogenetics
Hematologic Neoplasms
Fluorescence In Situ Hybridization
Molecular Biology
14 Citations (Scopus)

Medulloblastoma: II. A pathobiologic overview

Tomlinson, F. H., Scheithauer, B. W. & Jenkins, R. B., 1992, In : Journal of Child Neurology. 7, 3, p. 240-252 13 p.

Research output: Contribution to journalArticle

Primitive Neuroectodermal Tumors
Central Nervous System Neoplasms
Medulloblastoma
3 Citations (Scopus)

Mendelian randomisation study of the relationship between Vitamin D and risk of glioma

Takahashi, H., Cornish, A. J., Sud, A., Law, P. J., Kinnersley, B., Ostrom, Q. T., Labreche, K., Eckel-Passow, J. E., Armstrong, G. N., Claus, E. B., Ll'Yasova, D., Schildkraut, J., Barnholtz-Sloan, J. S., Olson, S. H., Bernstein, J. L., Lai, R. K., Schoemaker, M. J., Simon, M., Hoffmann, P., Nöthen, M. M. & 11 others, Jöckel, K. H., Chanock, S., Rajaraman, P., Johansen, C., Jenkins, R. B., Melin, B. S., Wrensch, M. R., Sanson, M., Bondy, M. L., Turnbull, C. & Houlston, R. S., Dec 1 2018, In : Scientific Reports. 8, 1, 2339.

Research output: Contribution to journalArticle

Random Allocation
Vitamin D
Glioma
Odds Ratio
Confidence Intervals
21 Citations (Scopus)

Meta-analysis of 8q24 for seven cancers reveals a locus between NOV and ENPP2 associated with cancer development

Brisbin, A. G., Asmann, Y., Song, H., Tsai, Y. Y., Aakre, J. A., Yang, P., Jenkins, R. B., Pharoah, P., Schumacher, F., Conti, D. V., Duggan, D. J., Jenkins, M., Hopper, J., Gallinger, S., Newcomb, P., Casey, G., Sellers, T. A. & Fridley, B. L., Dec 5 2011, In : BMC Medical Genetics. 12, 156.

Research output: Contribution to journalArticle

Meta-Analysis
Single Nucleotide Polymorphism
Neoplasms
Prostatic Neoplasms
Genes
101 Citations (Scopus)

Metastatic prostate carcinoma to bone: Clinical and pathologic features associated with cancer-specific survival

Cheville, J. C., Tindall, D., Boelter, C., Jenkins, R. B., Lohse, C. M., Pankratz, V. S., Sebo, T. J., Davis, B. & Blute, M. L., Sep 1 2002, In : Cancer. 95, 5, p. 1028-1036 9 p.

Research output: Contribution to journalArticle

Prostate
Neoplasm Metastasis
Carcinoma
Bone and Bones
Survival
106 Citations (Scopus)

MGMT immunohistochemical expression and promoter methylation in human glioblastoma

Rodriguez, F. J., Thibodeau, S. N., Jenkins, R. B., Schowalter, K. V., Caron, B. L., O'Neill, B. P., David James, C., Passe, S., Slezak, J. & Giannini, C., Jan 2008, In : Applied Immunohistochemistry and Molecular Morphology. 16, 1, p. 59-65 7 p.

Research output: Contribution to journalArticle

Methyltransferases
Glioblastoma
Methylation
DNA
Immunohistochemistry

MGMT immunohistochemical expression and promoter methylation in human glioblastoma (Applied Immunohistochemistry and Molecular Morphology (2008) 16, (59-65))

Rodriguez, F. J., Thibodeau, S. N., Jenkins, R. B., Schowalter, K. V., Caron, B. L., O'Neill, B. P., David James, C., Passe, S., Slezak, J. & Giannini, C., May 2008, In : Applied Immunohistochemistry and Molecular Morphology. 16, 3, p. 307 1 p.

Research output: Contribution to journalArticle

Glioblastoma
Methylation
Immunohistochemistry
29 Citations (Scopus)

MicroRNA-194 promotes prostate cancer metastasis by inhibiting SOCS2

Das, R., Gregory, P. A., Fernandes, R. C., Denis, I., Wang, Q., Townley, S. L., Zhao, S. G., Hanson, A. R., Pickering, M. A., Armstrong, H. K., Lokman, N. A., Ebrahimie, E., Davicioni, E., Jenkins, R. B., Karnes, R. J., Ross, A. E., Den, R. B., Klein, E. A., Chi, K. N., Ramshaw, H. S. & 7 others, Williams, E. D., Zoubeidi, A., Goodall, G. J., Feng, F. Y., Butler, L. M., Tilley, W. D. & Selth, L. A., Feb 15 2017, In : Cancer Research. 77, 4, p. 1021-1034 14 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Cytokines
Neoplasm Metastasis
GATA2 Transcription Factor
Phenotype
42 Citations (Scopus)

Microsatellite instability in hereditary and sporadic breast cancers

Adem, C., Soderberg, C. L., Cunningham, J. M., Reynolds, C., Sebo, T. J., Thibodeau, S. N., Hartmann, L. C. & Jenkins, R. B., Nov 20 2003, In : International Journal of Cancer. 107, 4, p. 580-582 3 p.

Research output: Contribution to journalArticle

Microsatellite Instability
DNA Mismatch Repair
Breast Neoplasms
Carcinoma, Intraductal, Noninfiltrating
Mutation
4 Citations (Scopus)

Modeling megakaryocyte development as a branching process

Therneau, T. M., Solberg, L. A. & Jenkins, R. B., 1989, In : Computers and Mathematics with Applications. 18, 10-11, p. 959-964 6 p.

Research output: Contribution to journalArticle

Branching process
Stochastic models
Computational methods
Stem cells
Large scale systems
20 Citations (Scopus)

Molecular Analysis of Low Grade Prostate Cancer Using a Genomic Classifier of Metastatic Potential

Klein, E. A., Santiago-Jiménez, M., Yousefi, K., Robbins, B. A., Schaeffer, E. M., Trock, B. J., Tosoian, J., Haddad, Z., Ra, S., Karnes, R. J., Jenkins, R. B., Cheville, J. C., Den, R. B., Dicker, A. P., Davicioni, E., Freedland, S. J. & Ross, A. E., Jan 1 2017, In : Journal of Urology. 197, 1, p. 122-128 7 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Neoplasm Grading
Nonparametric Statistics
Neoplasms
Logistic Models
49 Citations (Scopus)

Molecular analysis of metaplastic breast carcinoma: High EGFR copy number via aneusomy

Gilbert, J. A., Goetz, M. P., Reynolds, C. A., Ingle, J. N., Giordano, K. F., Suman, V. J., Blair, H. E., Jenkins, R. B., Lingle, W. L., Reinholz, M. M., Adjei, A. & Ames, M. M., Apr 1 2008, In : Molecular Cancer Therapeutics. 7, 4, p. 944-951 8 p.

Research output: Contribution to journalArticle

Epidermal Growth Factor Receptor
Breast Neoplasms
Mutation
Keratin-6
Keratin-5
47 Citations (Scopus)

Molecular cytogenetic analysis of chromosomes 1 and 19 in glioma cell lines

Law, M. E., Templeton, K. L., Kitange, G., Smith, J., Misra, A., Feuerstein, B. G. & Jenkins, R. B., Jul 1 2005, In : Cancer Genetics and Cytogenetics. 160, 1, p. 1-14 14 p.

Research output: Contribution to journalArticle

Chromosomes, Human, Pair 19
Chromosomes, Human, Pair 1
Cytogenetic Analysis
Glioma
Cell Line
17 Citations (Scopus)

Molecular genetics of astrocytomas and meningiomas

Dalrymple, S. J. & Jenkins, R. B., 1994, In : Current Opinion in Neurology. 7, 6, p. 477-483 7 p.

Research output: Contribution to journalArticle

Astrocytoma
Meningioma
Molecular Biology
Carcinogenesis
Tumor Suppressor Genes
2 Citations (Scopus)

Molecular subtyping of tumors from patients with familial glioma

Ruiz, V. Y., Praska, C. E., Armstrong, G., Kollmeyer, T. M., Yamada, S., Decker, P. A., Kosel, M. L., Eckel-Passow, J. E., Lachance, D. H., Bainbridge, M. N., Melin, B. S., Bondy, M. L. & Jenkins, R. B., May 18 2018, In : Neuro-Oncology. 20, 6, p. 810-817 8 p.

Research output: Contribution to journalArticle

Glioma
Isocitrate Dehydrogenase
Neoplasms
Molecular Probes
Mutation
313 Citations (Scopus)

Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: Guideline from the college of american pathologists, international association for the study of lung cancer, and association for molecular pathology

Lindeman, N. I., Cagle, P. T., Beasley, M. B., Chitale, D. A., Dacic, S., Giaccone, G., Jenkins, R. B., Kwiatkowski, D. J., Saldivar, J. S., Squire, J., Thunnissen, E. & Ladanyi, M., Jul 2013, In : Journal of Molecular Diagnostics. 15, 4, p. 415-453 39 p.

Research output: Contribution to journalArticle

Molecular Pathology
Epidermal Growth Factor Receptor
Protein-Tyrosine Kinases
Lung Neoplasms
Guidelines
285 Citations (Scopus)

Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: Guideline from the College of American Pathologists, International Association for the study of lung cancer, and Association for Molecular Pathology

Lindeman, N. I., Cagle, P. T., Beasley, M. B., Chitale, D. A., Dacic, S., Giaccone, G., Jenkins, R. B., Kwiatkowski, D. J., Saldivar, J. S., Squire, J., Thunnissen, E. & Ladanyi, M., Jun 2013, In : Archives of Pathology and Laboratory Medicine. 137, 6, p. 828-860 33 p.

Research output: Contribution to journalArticle

Molecular Pathology
Epidermal Growth Factor Receptor
Protein-Tyrosine Kinases
Lung Neoplasms
Guidelines
509 Citations (Scopus)

Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

Lindeman, N. I., Cagle, P. T., Beasley, M. B., Chitale, D. A., Dacic, S., Giaccone, G., Jenkins, R. B., Kwiatkowski, D. J., Saldivar, J. S., Squire, J., Thunnissen, E. & Ladanyi, M., Jul 2013, In : Journal of Thoracic Oncology. 8, 7, p. 823-859 37 p.

Research output: Contribution to journalArticle

Molecular Pathology
Epidermal Growth Factor Receptor
Protein-Tyrosine Kinases
Lung Neoplasms
Guidelines
41 Citations (Scopus)

Multi-parametric MRI and texture analysis to visualize spatial histologic heterogeneity and tumor extent in glioblastoma

Hu, L. S., Ning, S., Eschbacher, J. M., Gaw, N., Dueck, A., Smith, K. A., Nakaji, P., Plasencia, J., Ranjbar, S., Price, S. J., Tran, N., Loftus, J. C., Jenkins, R. B., O'Neill, B. P., Elmquist, W., Baxter, L. C., Gao, F., Frakes, D., Karis, J. P., Zwart, C. & 5 others, Swanson, K., Sarkaria, J. N., Wu, T., Mitchell, J. R. & Li, J., Nov 1 2015, In : PLoS One. 10, 11, e0141506.

Research output: Contribution to journalArticle

Glioblastoma
Magnetic resonance imaging
Tumors
Textures
texture
33 Citations (Scopus)

Mutation analysis of the putative tumor suppressor PTEN/MMAC1 in human ovarian cancer

Yokomizo, A., Tindall, D. J., Hartmann, L., Jenkins, R. B., Smith, D. I. & Liu, W., Jul 1998, In : International Journal of Oncology. 13, 1, p. 101-105 5 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Mutation
Neoplasms
Multiplex Polymerase Chain Reaction
DNA Sequence Analysis
34 Citations (Scopus)

Mutation and expression analysis of the p73 gene in prostate cancer

Yokomizo, A., Mai, M., Bostwick, D. G., Tindall, D. J., Qian, J., Cheng, L., Jenkins, R. B., Smith, D. I. & Liu, W., Apr 1 1999, In : Prostate. 39, 2, p. 94-100 7 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Mutation
Prostate
Genes
Tumor Suppressor Genes
49 Citations (Scopus)

MYC gene amplification is often acquired in lethal distant breast cancer metastases of unamplified primary tumors

Singhi, A. D., Cimino-Mathews, A., Jenkins, R. B., Lan, F., Fink, S. R., Nassar, H., Vang, R., Fetting, J. H., Hicks, J., Sukumar, S., De Marzo, A. M. & Argani, P., Mar 2012, In : Modern Pathology. 25, 3, p. 378-387 10 p.

Research output: Contribution to journalArticle

Gene Amplification
Breast Neoplasms
Neoplasm Metastasis
Neoplasms
Autopsy
19 Citations (Scopus)

Myxoinflammatory fibroblastic sarcoma showing t(2;6)(q31;p21.3) as a sole cytogenetic abnormality

Ida, C. M., Rolig, K. A., Hulshizer, R. L., Van Dyke, D. L., Randolph, J. L., Jenkins, R. B., Nascimento, A. G. & Oliveira, A. M., Sep 2007, In : Cancer Genetics and Cytogenetics. 177, 2, p. 139-142 4 p.

Research output: Contribution to journalArticle

Chromosome Aberrations
Sarcoma
Chromosomes
Reed-Sternberg Cells
Foot
6 Citations (Scopus)

Neuro-oncology practice: Understanding inherited genetic risk of adult glioma - A review

Rice, T., Lachance, D. H., Molinaro, A. M., Eckel-Passow, J. E., Walsh, K. M., Barnholtz-Sloan, J., Ostrom, Q. T., Francis, S. S., Wiemels, J., Jenkins, R. B., Wiencke, J. K. & Wrensch, M. R., Mar 20 2015, In : Neuro-Oncology Practice. 3, 1, p. 1-16 16 p., npv026.

Research output: Contribution to journalArticle

Glioma
Chromosomes, Human, Pair 8
Neoplasms
Astrocytoma
Histology
19 Citations (Scopus)

Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality

Tse, B. W. C., Volpert, M., Ratther, E., Stylianou, N., Nouri, M., McGowan, K., Lehman, M. L., McPherson, S. J., Roshan-Moniri, M., Butler, M. S., Caradec, J., Gregory-Evans, C. Y., McGovern, J., Das, R., Takhar, M., Erho, N., Alshalafa, M., Davicioni, E., Schaeffer, E. M., Jenkins, R. B. & 14 others, Ross, A. E., Karnes, R. J., Den, R. B., Fazli, L., Gregory, P. A., Gleave, M. E., Williams, E. D., Rennie, P. S., Buttyan, R., Gunter, J. H., Selth, L. A., Russell, P. J., Nelson, C. C. & Hollier, B. G., Jan 16 2017, (Accepted/In press) In : Oncogene.

Research output: Contribution to journalArticle

Neuropilin-1
Androgens
Prostate
Mortality
Neoplasms
389 Citations (Scopus)

Novel mutations of the MET proto-oncogene in papillary renal carcinomas

Schmidt, L., Junker, K., Nakaigawa, N., Kinjerski, T., Weirich, G., Miller, M., Lubensky, I., Neumann, H. P., Brauch, H., Decker, J., Vocke, C., Brown, J. A., Jenkins, R. B., Richard, S., Bergerheim, U., Gerrard, B., Dean, M., Linehan, W. M. & Zbar, B., Apr 8 1999, In : Oncogene. 18, 14, p. 2343-2350 8 p.

Research output: Contribution to journalArticle

Proto-Oncogenes
Papillary Carcinoma
Kidney
Mutation
Protein-Tyrosine Kinases
4 Citations (Scopus)

Novel PLA2G4C polymorphism as a molecular diagnostic assay for 19q loss in human gliomas

Hartmann, C., Johnk, L., Sasaki, H., Jenkins, R. B. & Louis, D. N., 2002, In : Brain Pathology. 12, 2, p. 178-182 5 p.

Research output: Contribution to journalArticle

Molecular Pathology
Glioma
Loss of Heterozygosity
Tumor Suppressor Genes
Exons
236 Citations (Scopus)

Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis

Gurel, B., Iwata, T., Koh, C. M., Jenkins, R. B., Lan, F., Van Dang, C., Hicks, J. L., Morgan, J., Cornish, T. C., Sutcliffe, S., Isaacs, W. B., Luo, J. & De Marzo, A. M., Sep 2008, In : Modern Pathology. 21, 9, p. 1156-1167 12 p.

Research output: Contribution to journalArticle

Nuclear Proteins
Prostate
Carcinogenesis
Prostatic Neoplasms
Proteins
65 Citations (Scopus)

Obesity and risk of esophageal adenocarcinoma and barrett's esophagus: A mendelian randomization study

Mayo Clinic Esophageal Adenocarcinoma and Barrett's Esophagus Registry Consortium, Ashman, J. B., Bouras, E. P., Cassivi, S. D., Crowell, M. D., De Groen, P., Erlichman, C., Fitch, T. R., Fleischer, D. E., Foxx-Orenstein, A. E., Halling, K. C., Houghton, L. A., Keaveny, A. P., Locke, G. R. & Martenson, J. A., Nov 1 2014, In : Journal of the National Cancer Institute. 106, 11, dju252.

Research output: Contribution to journalArticle

Barrett Esophagus
Random Allocation
Body Mass Index
Obesity
Adenocarcinoma
5 Citations (Scopus)

Oligodendroglial tumors with marked desmoplasia: Clinicopathologic and molecular features of 7 cases

Jentoft, M., Giannini, C., Rossi, S., Mota, R., Jenkins, R. B. & Rodriguez, F. J., Jun 2011, In : American Journal of Surgical Pathology. 35, 6, p. 845-852 8 p.

Research output: Contribution to journalArticle

Neoplasms
Oligodendroglioma
Mutation
Mitotic Index
Mutant Proteins
48 Citations (Scopus)

Oligodendroglioma cell lines containing t(1;19)(q10;p10)

Kelly, J. J. P., Blough, M. D., Stechishin, O. D. M., Chan, J. A. W., Beauchamp, D., Perizzolo, M., Demetrick, D. J., Steele, L., Auer, R. N., Hader, W. J., Westgate, M., Parney, I. F., Jenkins, R. B., Cairncross, J. G. & Weiss, S., Jul 2010, In : Neuro-Oncology. 12, 7, p. 745-755 11 p.

Research output: Contribution to journalArticle

Oligodendroglioma
Cell Line
temozolomide
Neoplastic Stem Cells
Brain Neoplasms
85 Citations (Scopus)

P16-Cdk4-Rb axis controls sensitivity to a cyclin-dependent kinase inhibitor PD0332991 in glioblastoma xenograft cells

Cen, L., Carlson, B. L., Schroeder, M. A., Ostrem, J. L., Kitange, G. J., Mladek, A. C., Fink, S. R., Decker, P. A., Wu, W., Kim, J. S., Waldman, T., Jenkins, R. B. & Sarkaria, J. N., Jul 2012, In : Neuro-Oncology. 14, 7, p. 870-881 12 p.

Research output: Contribution to journalArticle

Cyclin-Dependent Kinases
Glioblastoma
Heterografts
Cell Proliferation
Survival
35 Citations (Scopus)

Papillary renal cell carcinoma: Analysis of germline mutations in the MET proto-oncogene in a clinic-based population

Lindor, N. M., Dechet, C. B., Greene, M. H., Jenkins, R. B., Zincke, M. T., Weaver, A. L., Wilson, M., Zincke, H. & Liu, W., 2001, In : Genetic Testing. 5, 2, p. 101-106 6 p.

Research output: Contribution to journalArticle

Proto-Oncogenes
Germ-Line Mutation
Renal Cell Carcinoma
Exons
Population
60 Citations (Scopus)

Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers

Adem, C., Reynolds, C., Soderberg, C. L., Slezak, J. M., McDonnell, S. K., Sebo, T. J., Schaid, D. J., Myers, J. L., Sellers, T. A., Hartmann, L. C. & Jenkins, R. B., Jan 1 2003, In : Cancer. 97, 1, p. 1-11 11 p.

Research output: Contribution to journalArticle

Breast
Breast Neoplasms
Mutation
Control Groups
Mastectomy
13 Citations (Scopus)
methotrexate
cisplatin
Methotrexate
Cisplatin
Brain
54 Citations (Scopus)

P-glycoprotein-mediated resistance to Hsp90-directed therapy is eclipsed by the heat shock response

McCollum, A. K., TenEyck, C. J., Stensgard, B., Morlan, B. W., Ballman, K. V., Jenkins, R. B., Toft, D. O. & Erlichman, C., Sep 15 2008, In : Cancer Research. 68, 18, p. 7419-7427 9 p.

Research output: Contribution to journalArticle

Heat-Shock Response
P-Glycoprotein
tanespimycin
Small Interfering RNA
Therapeutics
186 Citations (Scopus)

Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North central cancer treatment group study N0177

Brown, P. D., Krishnan, S., Sarkaria, J. N., Wu, W., Jaeckle, K. A., Uhm, J. H., Geoffroy, F. J., Arusell, R., Kitange, G., Jenkins, R. B., Kugler, J. W., Morton, R. F., Rowland, K. M., Mischel, P., Yong, W. H., Scheithauer, B. W., Schiff, D., Giannini, C. & Buckner, J. C., Dec 1 2008, In : Journal of Clinical Oncology. 26, 34, p. 5603-5609 7 p.

Research output: Contribution to journalArticle

temozolomide
Glioblastoma
Radiotherapy
Epidermal Growth Factor Receptor
Neoplasms
541 Citations (Scopus)

Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: Long-term results of RTOG 9402

Cairncross, G., Wang, M., Shaw, E., Jenkins, R. B., Brachman, D., Buckner, J. C., Fink, K., Souhami, L., Laperriere, N., Curran, W. & Mehta, M., Jan 20 2013, In : Journal of Clinical Oncology. 31, 3, p. 337-343 7 p.

Research output: Contribution to journalArticle

Oligodendroglioma
Chemoradiotherapy
Lomustine
Procarbazine
Radiotherapy
568 Citations (Scopus)

Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group trial 9402

Cairncross, G., Berkey, B., Shaw, E., Jenkins, R. B., Scheithauer, B., Brachman, D., Buckner, J. C., Fink, K., Souhami, L., Laperierre, N., Mehta, M. & Curran, W., Jun 20 2006, In : Journal of Clinical Oncology. 24, 18, p. 2707-2714 8 p.

Research output: Contribution to journalArticle

Oligodendroglioma
Radiation Oncology
Lomustine
Procarbazine
Radiotherapy

Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)

Jaeckle, K. A., Anderson, S. K., Twohy, E. L., Dixon, J. G., Giannini, C., Jenkins, R. B., Egorin, M. J., Sarkaria, J. N., Brown, P. D., Flynn, P. J., Schwerkoske, J., Buckner, J. C. & Galanis, E., Jul 1 2019, In : Journal of neuro-oncology. 143, 3, p. 573-581 9 p.

Research output: Contribution to journalArticle

Oligodendroglioma
Astrocytoma
Neoplasms
Therapeutics
Anticonvulsants
53 Citations (Scopus)

Phase II trial of preirradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: RTOG br0131

Vogelbaum, M. A., Berkey, B., Peereboom, D., Macdonald, D., Giannini, C., Suh, J. H., Jenkins, R. B., Herman, J., Brown, P., Blumenthal, D. T., Biggs, C., Schultz, C. & Mehta, M., Apr 2009, In : Neuro-Oncology. 11, 2, p. 167-175 9 p.

Research output: Contribution to journalArticle

temozolomide
Oligodendroglioma
Astrocytoma
Radiotherapy
Drug Therapy
7 Citations (Scopus)

Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: long term results of RTOG BR0131

Vogelbaum, M. A., Hu, C., Peereboom, D. M., Macdonald, D. R., Giannini, C., Suh, J. H., Jenkins, R. B., Laack, N. N., Brachman, D. G., Shrieve, D. C., Souhami, L. & Mehta, M. P., Jun 19 2015, In : Journal of Neuro-Oncology. 124, 3, p. 413-420 8 p.

Research output: Contribution to journalArticle

temozolomide
Oligodendroglioma
Astrocytoma
Radiotherapy
Disease-Free Survival
210 Citations (Scopus)

Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: Efficacy and associations with chromosomal abnormalities

Buckner, J. C., Gesme, D., O'Fallon, J. R., Hammack, J. E., Stafford, S., Brown, P. D., Hawkins, R., Scheithauer, B. W., Erickson, B. J., Levitt, R., Shaw, E. G. & Jenkins, R. B., Jan 15 2003, In : Journal of Clinical Oncology. 21, 2, p. 251-255 5 p.

Research output: Contribution to journalArticle

Lomustine
Procarbazine
Oligodendroglioma
Vincristine
Chromosome Aberrations
602 Citations (Scopus)

Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: A north central cancer treatment group study

Galanis, E., Buckner, J. C., Maurer, M. J., Kreisberg, J. I., Ballman, K., Boni, J., Peralba, J. M., Jenkins, R. B., Dakhil, S. R., Morton, R. F., Jaeckle, K. A., Scheithauer, B. W., Dancey, J., Hidalgo, M. & Walsh, D. J., 2005, In : Journal of Clinical Oncology. 23, 23, p. 5294-5304 11 p.

Research output: Contribution to journalArticle

Glioblastoma
Neoplasms
Sirolimus
Therapeutics
Anticonvulsants